Ana Belo van Wijk, PhD,  —

E-cigarettes are Poor Substitutes for Conventional Smoking in COPD Patients

E-cigarettes are not at all beneficial for chronic obstructive pulmonary disease (COPD) patients trying to quit smoking or to mitigate the health consequences of nicotine, according to a new study. The study reporting the findings was published in the Journal of General Internal Medicine and is titled “…

Phase 3 Trials Show GSK’s Nucala Can Reduce Exacerbations in Specific COPD Patients

Two Phase 3 clinical trials demonstrated that the antibody Nucala (mepolizumab) from GlaxoSmithKline has a moderate efficacy in the reduction of the rate of exacerbations in chronic obstructive pulmonary disease (COPD) patients. The almost 20 percent decrease in the exacerbation rate was only observed in COPD patients with high levels of…